News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
74,274 Results
Type
Article (1924)
Company Profile (2)
Press Release (72348)
Section
Business (25333)
Career Advice (9)
Deals (4555)
Drug Development (8158)
FDA (1806)
Job Trends (799)
News (37022)
Policy (3563)
Tag
2027 BioCapital Standard (1)
Academia (102)
Accelerated approval (5)
ADA (2)
Allergies (27)
Alliances (8166)
ALS (23)
Alzheimer's disease (194)
Antibody-drug conjugate (ADC) (146)
Approvals (1998)
Artificial intelligence (42)
ASCO (37)
Autoimmune disease (44)
Automation (3)
Bankruptcy (10)
Best Places to Work (584)
BIO (11)
Biologics (8)
Biosimilars (109)
BioSpace Insights (1)
Biotechnology (5)
Bispecific (10)
Bladder cancer (34)
Brain cancer (8)
Breast cancer (68)
Cancer (731)
Cardiovascular disease (31)
Career advice (9)
CAR-T (19)
CDC (2)
CDMO (13)
Celiac Disease (1)
Cell therapy (69)
Cervical cancer (5)
Clinical research (7872)
Collaboration (365)
Commercialization (16)
Compensation (28)
Complete response letters (8)
COVID-19 (203)
CRISPR (1)
C-suite (118)
Cystic fibrosis (9)
Data (1000)
Depression (18)
Dermatology (21)
Diabetes (56)
Diagnostics (663)
Digital health (8)
Drug discovery (47)
Drug pricing (1)
Duchenne muscular dystrophy (52)
Earnings (8316)
ESMO (50)
Events (7765)
Executive appointments (81)
Eye disease (1)
FDA (2393)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (172)
Gene editing (7)
Generative AI (1)
Gene therapy (45)
GLP-1 (89)
Government (246)
Grass and pollen (1)
Guidances (41)
Healthcare (1103)
Hematology (18)
HIV (7)
Huntington's disease (3)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (31)
Immunology and inflammation (8)
Immuno-oncology (15)
Indications (36)
Infectious disease (233)
Inflammatory bowel disease (27)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (45)
IPO (1640)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Kidney disease (13)
Layoffs (6)
Legal (953)
Licensing (31)
Liver cancer (22)
Longevity (3)
Lung cancer (141)
Lung diease (3)
Lymphoma (64)
Machine learning (1)
Manufacturing (164)
Marketing (10)
MASH (20)
Medical device (1181)
Medtech (1202)
Mergers & acquisitions (3138)
Metabolic disorders (133)
mRNA (11)
Multiple sclerosis (30)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (383)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (45)
Opinion (1)
Ovarian cancer (37)
Pain (24)
Pancreatic cancer (35)
Parkinson's disease (53)
Partnered (4)
Patents (82)
Patient recruitment (94)
Patient selection (19)
Peanut (2)
People (5244)
Peptides (2)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2118)
Phase 2 (3342)
Phase 3 (2978)
Pipeline (1617)
Policy (1)
Postmarket research (241)
Preclinical (717)
Press Release (2)
Prostate cancer (31)
Radiopharmaceuticals (30)
Rare diseases (103)
Real estate (608)
Regenerative medicine (6)
Regulatory (3158)
Reports (10)
Research institute (98)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (27)
Series A (38)
Series B (25)
Service/supplier (1)
Sickle cell disease (9)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (425)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (15)
Switzerland (7)
Vaccines (52)
Venture capital (7)
Weight loss (21)
Women's health (10)
Date
Today (6)
Last 7 days (99)
Last 30 days (294)
Last 365 days (2903)
2026 (2514)
2025 (2684)
2024 (3253)
2023 (3815)
2022 (7003)
2021 (6371)
2020 (5870)
2019 (3857)
2018 (3013)
2017 (3561)
2016 (3172)
2015 (4029)
2014 (3021)
2013 (2602)
2012 (2775)
2011 (2902)
2010 (2666)
Location
Africa (89)
Alabama (5)
Arizona (14)
Arkansas (1)
Asia (22478)
Australia (2505)
California (925)
Canada (525)
China (605)
Colorado (6)
Connecticut (30)
Delaware (9)
Europe (13683)
Florida (99)
Georgia (18)
Hawaii (1)
Illinois (50)
India (71)
Indiana (36)
Japan (398)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (140)
Massachusetts (740)
Michigan (9)
Minnesota (41)
Missouri (3)
Nebraska (3)
Nevada (16)
New Hampshire (1)
New Jersey (589)
New York (310)
North Carolina (142)
Northern California (406)
Ohio (7)
Oregon (1)
Pennsylvania (178)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (451)
Tennessee (6)
Texas (70)
United States (3561)
Utah (39)
Vermont (1)
Virginia (74)
Washington D.C. (3)
Washington State (67)
Wisconsin (9)
Wyoming (1)
74,274 Results for "biolinerx ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Press Releases
Transpharmation Ltd. Announces Strategic Acquisition of OrganoTherapeutics SARL
October 28, 2026
·
5 min read
Press Releases
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
October 29, 2026
·
7 min read
Press Releases
TempraMed Technologies Ltd. Announces Closing of Private Placement
October 1, 2026
·
5 min read
Business
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
BioLineRx Ltd. reported its unaudited financial results for the first quarter ended March 31, 2024, and provided recent corporate and portfolio updates.
May 28, 2024
·
17 min read
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification - May 17, 2024
BioLineRx Ltd., a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, announced that it has received a notification letter from the Nasdaq Stock Market LLC.
May 17, 2024
·
6 min read
Business
BioLineRx to Report 2023 Annual Financial Results on March 26, 2024
BioLineRx Ltd. today announced it will release its audited financial results for the year ended December 31, 2023 on Tuesday, March 26, 2024, before the U.S. markets open.
March 20, 2024
·
1 min read
Press Releases
J-Star Holding Co., Ltd. Provides Update on Capital Structure Authorization and Strategic Execution Timeline
November 4, 2026
·
2 min read
Business
BioLineRx to Report First Quarter 2024 Results on May 28, 2024
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the quarter ended March 31, 2024 on Tuesday, May 28, 2024, before the U.S. markets open.
May 22, 2024
·
1 min read
Business
BioLineRx Reports 2023 Financial Results and Recent Corporate and Portfolio Updates
BioLineRx Ltd., a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, reported its financial results for the year ended December 31, 2023, and provided recent corporate and portfolio updates.
March 26, 2024
·
19 min read
1 of 7,428
Next
